Does type 2 diabetes affect the on-treatment levels of direct oral anticoagulants in patients with atrial fibrillation? [0.03%]
2型糖尿病会影响房颤患者口服抗凝药的稳态浓度吗？
Matej Samoš,Tomáš Bolek,Lucia Stančiaková et al.
Matej Samoš et al.
Aims: Type 2 diabetes (T2D) is connected with several abnormalities in haemostasis; and with higher risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NV-AF). However, it is recently u...
Increased sugar intake as a form of compensatory hyperphagia in patients with type 2 diabetes under dapagliflozin treatment [0.03%]
达格列净治疗2型糖尿病患者代偿性过度进食的糖分摄入增加现象
Ichiro Horie,Norio Abiru,Ryoko Hongo et al.
Ichiro Horie et al.
Aims: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) cause substantially less weight loss than would be expected based on their caloric deficits, probably due to enhanced appetite regulation known as "compensatory hyp...
Higher prevalence and earlier appearance of geriatric phenotypes in old adults with type 2 diabetes mellitus [0.03%]
2型糖尿病老年患者老化表型的更高患病率及更早出现的时间点
Marina Kotsani,Thekla Chatziadamidou,Dimitrios Economides et al.
Marina Kotsani et al.
Aims: To compare the prevalence of cognitive dysfunction, depression, lower mobility performance, disability and falls in older community-dwelling individuals with type 2 diabetes mellitus (T2DM) and in controls of simila...
Risk of type 2 diabetes mellitus associated with plasma lipid levels: The rural Chinese cohort study [0.03%]
中国农村队列人群中糖尿病患病风险与血浆脂蛋白水平的关系研究
Ming Zhang,Junmei Zhou,Yu Liu et al.
Ming Zhang et al.
Aim: To investigate the association of type 2 diabetes mellitus (T2DM) risk and plasma lipid levels in rural Chinese. Methods: Each lip...
Depressive symptoms and glycemic control in youth with type 2 diabetes participating in the TODAY clinical trial [0.03%]
青春期糖尿病患者的抑郁症状和血糖控制-TODAY临床试验数据
Dorothy J Van Buren,Denise E Wilfley,Marsha D Marcus et al.
Dorothy J Van Buren et al.
The relationship between depressive symptoms and glycemic control in youth with type 2 diabetes was assessed at baseline (n = 682), 6, and/or 24 months (n = 576). Neither baseline nor persistence of depressive symptoms was significantly ass...
Randomized Controlled Trial
Diabetes research and clinical practice. 2018 Jan:135:85-87. DOI:10.1016/j.diabres.2017.11.008 2018
Paddy C Dempsey,David W Dunstan,Robyn N Larsen et al.
Paddy C Dempsey et al.
Fatigue is a prevalent, costly and disabling clinical complaint among those with type 2 diabetes. In a randomized crossover trial, prolonged uninterrupted sitting increased fatigue by 29% relative to days when sitting was regularly interrup...
Randomized Controlled Trial
Diabetes research and clinical practice. 2018 Jan:135:128-133. DOI:10.1016/j.diabres.2017.11.001 2018
Predictors of insulin uptake among adults with type 2 diabetes in the Stepping Up Study [0.03%]
stepper up研究中2型糖尿病成人使用胰岛素的预测因素
Elizabeth Holmes-Truscott,John Furler,Irene Blackberry et al.
Elizabeth Holmes-Truscott et al.
Aims: We aimed to investigate predictors of insulin uptake, and change in insulin appraisals, among adults with type 2 diabetes mellitus (T2DM) who participated in the Stepping Up trial. ...
Randomized Controlled Trial
Diabetes research and clinical practice. 2017 Nov:133:204-210. DOI:10.1016/j.diabres.2017.01.002 2017
The association of inflammatory markers and periodontal indexes with the risk of coronary heart disease in Chinese patients with type 2 diabetes mellitus [0.03%]
中国2型糖尿病患者中冠心病发病风险与牙周及炎症标志物的关系
Ling Chen,Bin Wei,Liang Xu et al.
Ling Chen et al.
Objectives: The present study was designed to investigate the association of four inflammatory markers and five periodontal indexes with the risk of coronary heart disease (CHD) in 131 patients with type 2 diabetes mellit...
Leukocyte telomere length correlates with glucose control in adults with recently diagnosed type 2 diabetes [0.03%]
新诊断的2型糖尿病成人中白细胞端粒长度与血糖控制相关性研究
Erica Carine Campos Caldas Rosa,Renan Renato Cruz Dos Santos,Luis Fernando Amarante Fernandes et al.
Erica Carine Campos Caldas Rosa et al.
Aims: We investigated leukocyte relative telomere length (TL) in patients with type 2 diabetes (T2D) diagnosed for no longer than five years and its association with clinical and biochemical variables. ...
Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients [0.03%]
2型糖尿病患者肝纤维化评分的纵向变化趋势分析
Carlo Bruno Giorda,Gabriele Forlani,Roberta Manti et al.
Carlo Bruno Giorda et al.
Aims: The prevalence and progression of hepatic fibrosis and its correlated factors in type 2 diabetes (T2DM) are poorly known. We aimed to define the percentage of T2DM patients who progress to fibrosis and the factors a...